nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase I study of single-agent BEZ235 special delivery system sachet in Japanese patients with advanced solid tumors
|
Toyoda, Masanori |
|
2018 |
83 |
2 |
p. 289-299 |
artikel |
2 |
A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities
|
Foster, Jennifer H. |
|
2018 |
83 |
2 |
p. 349-360 |
artikel |
3 |
Gemcitabine and metabolite pharmacokinetics in advanced NSCLC patients after bronchial artery infusion and intravenous infusion
|
Alharbi, Abeer F. |
|
2018 |
83 |
2 |
p. 387-391 |
artikel |
4 |
Knockdown of long non-coding HOTAIR enhances the sensitivity to progesterone in endometrial cancer by epigenetic regulation of progesterone receptor isoform B
|
Chi, Shuqi |
|
2018 |
83 |
2 |
p. 277-287 |
artikel |
5 |
Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours—the MACBETH project
|
Cazzaniga, Marina E. |
|
2018 |
83 |
2 |
p. 301-318 |
artikel |
6 |
6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability
|
Du, Shengnan |
|
2018 |
83 |
2 |
p. 237-254 |
artikel |
7 |
Murine RAW264.7 cells as cellular drug delivery carriers for tumor therapy: a good idea?
|
Zheng, Huangliang |
|
2018 |
83 |
2 |
p. 361-374 |
artikel |
8 |
Octreotide SC depot in patients with acromegaly and functioning neuroendocrine tumors: a phase 2, multicenter study
|
Pavel, Marianne |
|
2018 |
83 |
2 |
p. 375-385 |
artikel |
9 |
Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals
|
Bolger, Gordon T. |
|
2018 |
83 |
2 |
p. 265-275 |
artikel |
10 |
Population pharmacokinetic and covariate analyses of intravenous trastuzumab (Herceptin®), a HER2-targeted monoclonal antibody, in patients with a variety of solid tumors
|
Quartino, Angelica L. |
|
2018 |
83 |
2 |
p. 329-340 |
artikel |
11 |
Population pharmacokinetics and exposure–response assessment of veliparib co-administered with temozolomide in patients with myeloid leukemias
|
Singh, Renu |
|
2018 |
83 |
2 |
p. 319-328 |
artikel |
12 |
Prevalence of TPMT, ITPA and NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with acute lymphoblastic leukemia
|
Khera, Sanjeev |
|
2018 |
83 |
2 |
p. 341-348 |
artikel |
13 |
Role of the HDAC6/STAT3 pathway in regulating PD-L1 expression in osteosarcoma cell lines
|
Keremu, Ajimu |
|
2018 |
83 |
2 |
p. 255-264 |
artikel |
14 |
Toll-like receptor/interleukin-1 domain innate immune signalling pathway genetic variants are candidate predictors for severe gastrointestinal toxicity risk following 5-fluorouracil-based chemotherapy
|
Korver, Samantha K. |
|
2018 |
83 |
2 |
p. 217-236 |
artikel |